New York State Teachers Retirement System Has $6.42 Million Stock Position in Encompass Health Corporation $EHC

New York State Teachers Retirement System lessened its stake in shares of Encompass Health Corporation (NYSE:EHCFree Report) by 8.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 66,389 shares of the company’s stock after selling 6,451 shares during the period. New York State Teachers Retirement System’s holdings in Encompass Health were worth $6,422,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in EHC. Northwestern Mutual Wealth Management Co. increased its position in shares of Encompass Health by 3,059,159.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after acquiring an additional 3,793,358 shares in the last quarter. Norges Bank purchased a new stake in shares of Encompass Health in the 4th quarter valued at approximately $133,221,000. Price T Rowe Associates Inc. MD boosted its stake in Encompass Health by 24.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock worth $510,047,000 after purchasing an additional 948,202 shares during the period. Millennium Management LLC grew its position in Encompass Health by 140.0% during the 3rd quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock worth $155,430,000 after purchasing an additional 713,738 shares in the last quarter. Finally, 8 Knots Management LLC purchased a new position in Encompass Health during the 2nd quarter worth approximately $78,644,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Price Performance

EHC opened at $110.52 on Wednesday. The stock has a market cap of $10.96 billion, a price-to-earnings ratio of 18.45, a PEG ratio of 2.33 and a beta of 0.74. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The stock has a fifty day moving average price of $103.37 and a 200 day moving average price of $103.41.

Encompass Health (NYSE:EHCGet Free Report) last issued its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same period in the prior year, the firm posted $1.37 EPS. The business’s revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Analysts forecast that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is presently 12.69%.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the sale, the executive vice president directly owned 24,755 shares in the company, valued at $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

EHC has been the subject of a number of research analyst reports. Barclays reduced their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. TD Cowen assumed coverage on Encompass Health in a research report on Thursday, May 28th. They set a “buy” rating and a $125.00 price objective for the company. Leerink Partners set a $152.00 target price on Encompass Health in a report on Friday, May 22nd. Finally, Weiss Ratings lowered shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $143.86.

Read Our Latest Stock Report on Encompass Health

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Recommended Stories

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHCFree Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.